Overview

PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study is aimed at finding the effect of PulseHaler™ with Albuterol on Lung Deposition of Aerosol and on Pulmonary Functions in COPD Patients
Phase:
N/A
Details
Lead Sponsor:
Respinova LTD
Treatments:
Albuterol